Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

NPS Pharmaceuticals initiates clinical trials for NPS-1776

Oct. 1, 1998

New arthritis Rx now available in Japan

Sep. 30, 1998

Selectin inhibitors under study at Kanebo

Sep. 28, 1998

TheraTech receives NIH funding for novel approach to rheumatoid arthritis

Sep. 24, 1998

Mitsui Chemicals prepares cell adhesion inhibitors

Sep. 24, 1998

PAF antagonist evaluated in patients with rheumatoid arthritis; results disappointing

Sep. 22, 1998

Novel antiinflammatory azulenes disclosed by Kotobuki

Sep. 21, 1998

Selective and sensitive p38 MAP kinase inhibitor identified by SmithKline Beecham

Sep. 18, 1998

La Jolla identifies target of antibodies responsible for life-threatening autoimmune disorder

Sep. 17, 1998

Medical device for rheumatoid arthritis scheduled for October advisory panel review

Sep. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...